Hunan Jingfeng Pharmaceutical Co.,Ltd.
000908.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$10.59B
Close$
$0.40
92.9% downside
Current Fair Value
92.9% downsideOvervalued by 92.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $10.59 Billion |
|---|---|
| Enterprise Value | $9.20 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.09 |
| Beta | -0.5 |
| Outstanding Shares | 1,756,548,702 |
Return
| Return on Equity | -2.03% |
|---|---|
| Return on Assets | -1.74% |
| Return on Invested Capital | -1.83% |
Valuation & Multiples
| P/E Ratio | -121.13 |
|---|---|
| PEG | 109.48 |
| Price to Sales | - |
| Price to Book Ratio | 5.61 |
| Enterprise Value to Revenue | 23.16 |
| Enterprise Value to EBIT | -244.07 |
| Enterprise Value to Net Income | -217 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Hunan Jingfeng Pharmaceutical Co.,Ltd.
463 employees
CEO: Xiang Wu Ye Hunan Jingfeng Pharmaceutical Co.,Ltd., established in 2003 and headquartered in Shanghai, China, operates as a manufacturer and supplier of various pharmaceutical products, including chemical compounds and biological agents, within the ...